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Abstract 
We previously reported that lysophosphatidic acid (LPA) inhibits the neuronal differentiation of human 
embryonic stem cells (hESC). We extended these studies by analyzing LPA's effects on the expansion of 
neural stem/ progenitor cells (NS/PC) derived from hESCs and human induced pluripotent stem cells 
(iPSC), and we assessed whether data obtained on the neural differentiation of hESCs were relevant to 
iPSCs. We showed that hESCs and iPSCs exhibited comparable mRNA expression profiles of LPA 
receptors and producing enzymes upon neural differentiation. We demonstrated that LPA inhibited the 
expansion of NS/PCs of both origins, mainly by increased apoptosis in a Rho/Rho-associated kinase 
(ROCK)-dependent mechanism. Furthermore, LPA inhibited the neuronal differentiation of iPSCs. Lastly, 
LPA induced neurite retraction of NS/ PC-derived early neurons through Rho/ROCK, which was 
accompanied by myosin light chain (MLC) phosphorylation. Our data demonstrate the consistency of LPA 
effects across various sources of human NS/PCs, rendering hESCs and iPSCs valuable models for 
studying lysophospholipid signaling in human neural cells. Our data also highlight the importance of the 
Rho/ROCK pathway in human NS/ PCs. As LPA levels are increased in the central nervous system (CNS) 
following injury, LPA-mediated effects on NS/ PCs and early neurons could contribute to the poor 
neurogenesis observed in the CNS following injury. 
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 Lysophosphatidic acid (LPA) is a bioactive lysophospho-
lipid that induces pleiotropic effects in many cell types. 
LPA mainly acts through binding to its specifi c G-protein-
coupled receptors LPA 1–5 , which can couple to G i , G q , G 12 , 
and possibly G s , to modulate specifi c downstream signal-
ing pathways ( 1 ). LPA can also activate the purinergic re-
ceptors LPA 6 /P2Y5 ( 2 ), GPR87 ( 3 ), and P2Y10 ( 4 ), the 
transient receptor potential vanilloid receptor 1 cation 
channel (TRPV1) ( 5 ), and the intracellular peroxisome 
proliferator-activator receptor (PPAR)   ( 6 ). LPA recep-
tors are expressed in various types of stem cells and dem-
onstrate a differential expression profi le across various 
cells and tissues ( 7, 8 ). LPA can be synthesized both in-
tracellularly and extracellularly by activation of different 
enzymes ( 1 ); however, it is not yet entirely clear whether 
or how intracellular LPA contributes to extracellular sig-
naling. Although LPA can be synthesized extracellularly 
by secreted phospholipases A, in particular by the se-
creted PLA 2 group IIA (sPLA 2 ), a major source of extra-
cellular LPA in the central nervous system (CNS) most 
probably arises from the activity of the secreted lyso-
phospholipase D enzyme autotaxin (ATX), as this enzyme 
 Abstract  We previously reported that lysophosphatidic 
acid (LPA) inhibits the neuronal differentiation of human 
embryonic stem cells (hESC). We extended these studies by 
analyzing LPA’s effects on the expansion of neural stem/
progenitor cells (NS/PC) derived from hESCs and human 
induced pluripotent stem cells (iPSC), and we assessed 
whether data obtained on the neural differentiation of 
hESCs were relevant to iPSCs. We showed that hESCs and 
iPSCs exhibited comparable mRNA expression profi les of 
LPA receptors and producing enzymes upon neural differ-
entiation. We demonstrated that LPA inhibited the expansion 
of NS/PCs of both origins, mainly by increased apoptosis 
in a Rho/Rho-associated kinase (ROCK)-dependent mecha-
nism. Furthermore, LPA inhibited the neuronal differentia-
tion of iPSCs. Lastly, LPA induced neurite retraction of NS/
PC-derived early neurons through Rho/ROCK, which was 
accompanied by myosin light chain (MLC) phosphoryla-
tion.  Our data demonstrate the consistency of LPA effects 
across various sources of human NS/PCs, rendering 
hESCs and iPSCs valuable models for studying lysophospho-
lipid signaling in human neural cells. Our data also highlight 
the importance of the Rho/ROCK pathway in human NS/
PCs. As LPA levels are increased in the central nervous sys-
tem (CNS) following injury, LPA-mediated effects on NS/
PCs and early neurons could contribute to the poor neu-
rogenesis observed in the CNS following injury. —Frisca, 
F., D. E. Crombie, M. Dottori, Y. Goldshmit, and A. Pébay. 
 Rho/ROCK pathway is essential to the expansion, differ-
entiation, and morphological rearrangements of human 
neural stem/progenitor cells induced by lysophosphatidic 
acid.  J. Lipid Res.  2013.  54:  1192–1206. 
 This work was supported by a National Health and Medical Research Council 
of Australia Career Development Award Fellowship (A.P.), a Transport Acci-
dent Commission project grant (A.P.), and the Victorian State Government’s 
Department of Innovation, Industry and Regional Development’s Operational 
Infrastructure Support Program. F.F. received an Australian Development 
Scholarship (ADS) by the Australian government (AusAID). 
 Manuscript received 15 September 2012 and in revised form 1 March 2013. 
 Published, JLR Papers in Press, March 4, 2013 
 DOI 10.1194/jlr.M032284 
 Rho /ROCK pathway is essential to the expansion, 
differentiation, and morphological rearrangements 
of human neural stem/progenitor cells induced by 
lysophosphatidic acid  
 Frisca  Frisca, *  Duncan E.  Crombie, * ,†  Mirella  Dottori, §  Yona  Goldshmit, †, ** and  Alice  Pébay 1, * ,† 
 Department of Ophthalmology,*  University of Melbourne , East Melbourne VIC,  Australia ; Centre for 
Eye Research, †  Australia & Royal Victorian Eye and Ear Hospital , East Melbourne VIC,  Australia ; 
Department of Anatomy and Neurosciences, §  University of Melbourne , Parkville VIC,  Australia ; and 
Australian Regenerative Medicine Institute,**  Monash University , Clayton, VIC,  Australia 
 Abbreviations: ATX, autotaxin; bFGF, basic fi broblast growth fac-
tor; CNS, central nervous system; EFG, epidermal growth factor; hESC, 
human embryonic stem cell; hPSC, human pluripotent stem cell; iPSC, 
induced pluripotent stem cell; LPA, lysophosphatidic acid; MLC, myo-
sin light chain; NBM, neural basal media; NEP, neuroepithelium cell 
line; NS/PC, neural stem/progenitor cell; ROCK, Rho-associated ki-
nase; TUNEL, terminal transferase dUTP nick end labeling. 
 1 To whom correspondence should be addressed.  
 e-mail: apebay@unimelb.edu.au 
  The online version of this article (available at http://www.jlr.org) 



















Supplemental Material can be found at:
LPA modulates human neural progenitor cells 1193
heterogeneity of cell populations, species, LPA receptor 
expression profi les, LPA concentration used, and the cul-
ture conditions of the cell lines. In rodents, LPA was 
reported to stimulate, inhibit, or not affect NS/PC prolif-
eration ( 13–16 ). Further, LPA has been shown to be a sur-
vival factor, a pro-apoptotic agent or a prodifferentiation 
factor of NS/PCs ( 16–18 ). Comparably, LPA has also been 
described as a proliferative, survival, or prodifferentiation 
factor in some neuroblasts but not all ( 8 ). It was recently 
shown that LPA can induce fetal hydrocephalus in the 
mouse by an aberrant activation of Lpa 1 on NS/PCs dur-
ing development ( 19 ). LPA also acts through the Rho 
pathway to induce morphological rearrangements in neu-
roblasts and neurons ( 20–24 ), including actin polymeriza-
tion ( 21 ) that leads to the formation of retraction fi bers, 
neurite retraction ( 21, 25–32 ), cell rounding ( 26, 29, 33, 
34 ), cluster compaction ( 35–38 ), and growth cone col-
lapse ( 21, 26, 27 ). 
 The study of LPA in human NS/PCs and neurons is still 
extremely limited. Although we briefl y reported that LPA 
inhibits the ability of hESC-derived NS/PCs to form neu-
rospheres, we did not attempt to characterize this biologi-
cal effect and the signaling pathways associated ( 39 ). We 
also previously showed that when two-week-old hESC-de-
rived neurospheres were plated onto laminin or fi bronec-
tin, LPA inhibited their neuronal differentiation through 
the Rho/ROCK and phosphatidylinositol 3-kinase (PI3K)/
Akt pathways ( 39 ). This effect was linked to an antidiffer-
entiation effect of LPA, as no modifi cation in apoptosis or 
proliferation could be detected on these plated neuro-
spheres ( 39 ). Hurst and colleagues, however, reported 
that LPA stimulates proliferation and cell-rounding of 
hESC-derived neuroepithelium cell line (NEP), a stable 
line enriched in hESC-derived NS/PCs and grown under 
adherent conditions ( 40, 41 ). These variations may be due 
to culture conditions or cell origin. 
 Here and given the potential differences of hESCs and 
human iPSCs, we dissected LPA’s effects on the progres-
sive neural differentiation on both types of hPSCs, thus 
allowing to directly compare LPA signaling in hESCs and 
human iPSCs. Our differentiation protocol allows to as-
sess effects of LPA on NS/PCs during their neural dif-
ferentiation and on NS/PC-derived neurons. While our 
previous study concentrated on the impact of LPA on the 
neuronal and glial differentiation of hESC-derived NS/
PCs ( 39 ), this current study assessed the effects of LPA at 
an earlier stage of neuralization, namely, the expansion 
of NS/PCs, from both hESCs and human iPSCs. Further, 
we assessed whether the data obtained on the neuronal 
and glial differentiation of hESCs were relevant to hu-
man iPSCs, allowing us to draw conclusions on the simi-
larity of LPA’s effects across these two different cell types. 
Finally, we assessed LPA’s effects on the morphology of 
early human neurons derived from NS/PCs. This study 
thus provides a comprehensive assessment of the role of 
LPA in these various differentiation stages on hESCs and 
human iPSCs. Because LPA is released upon infl amma-
tion and is involved in neurotrauma and various CNS 
diseases ( 1 ), appreciating its role on neurogenesis and 
is found to be expressed in various CNS regions during 
development or adulthood, and its activity is modifi ed fol-
lowing various physiopathological events ( 1 ). In the CNS, 
LPA can target most cell types and plays roles in a variety 
of developmental and pathological processes, including 
neurogenesis, neuropathic pain, neural injury, schizo-
phrenia, epilepsy, and memory impairment ( 1 ). 
 Neural stem/progenitor cells (NS/PC) have been ex-
tensively studied, with the aim of using endogenous and/
or donor NS/PCs to replace neurons and restore circuitry 
in a neurodegenerative microenvironment. In theory, hu-
man embryonic stem cells (hESC) and human induced 
pluripotent stem cells (iPSC) are a great source of cells to 
generate NS/PCs and progeny, which could potentially be 
used for transplantation and also to provide insight into 
human neurogenesis. Although not identical, hESCs and 
iPSCs seem very similar, but the extent of the variations 
and similarities between the two types of cells remains 
open ( 9 ). Hence, comparing their differentiation poten-
tials and response to specifi c signaling molecules is still 
required to allow drawing conclusions on whether hESCs 
and iPSCs show critical differences. It was previously shown 
in hESCs that the bone morphogenetic protein inhibitor 
noggin induces neuroectodermal differentiation, as shown 
by the expression of SOX2, paired box protein 6, and nes-
tin and a lack of expression of early mesoderm or endo-
derm markers ( 10 ). Once dissected, these colonies are 
propagated in suspension in neural basal media (NBM) 
supplemented with basic fi broblast growth factor (bFGF) 
and epidermal growth factor (EGF), where they aggregate 
and form a spherical-like cluster named neurosphere, 
which consists of a heterogeneous population of NS/PCs 
( 10 ). Neurospheres can be differentiated to give rise to 
neurons and glia when plated onto laminin or fi bronectin 
substrates, respectively. Hence, this differentiation proto-
col allows the progressive neural patterning of human 
pluripotent stem cells (hPSC, noggin stage), effi cient gen-
eration and expansion of NS/PCs (neurosphere stage), 
and subsequent differentiation into early neurons and 
glial cells ( 11 ). Other protocols of differentiation have 
been established for hESCs ( 12 ), including protocols that 
maintain NS/PCs as a monolayer instead of a neurosphere, 
but they are less defi ned. This overall method allows to 
precisely divide the whole differentiation process into de-
fi ned stages and to effi ciently generate human neural pro-
genitors and early neurons, rendering this technique 
robust and well defi ned. These features make this proto-
col highly useful for the study of fundamental signaling 
mechanisms involved in NS/PC multipotency and expan-
sion. Unraveling these mechanisms may allow for better 
and more effi cient techniques to use human NS/PCs, ei-
ther endogenous or exogenous, to treat neurodegenera-
tion and infl ammation of the CNS by characterizing, for 
instance, how the cellular environment modifi es NS/PC 
fate in term of survival and differentiation. 
 LPA’s effects on NS/PCs and neuroblasts seem to vary 
depending on the origin of the cells ( 8 ). These differ-
ences might be the consequence of discrepancies in terms 
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appropriate conjugated secondary antibodies (Alexa Fluor 555 
or 488, Cy3, Molecular Probes-Invitrogen). Nuclei were coun-
terstained with 4 ′ ,6-diamidino-2-pheylindole (DAPI, 1:1000, 
Sigma-Aldrich). Specifi city of the staining was verifi ed by the 
appropriate negative control immunoglobulin fraction (see 
 Fig. 4G, H ,  Fig. 5F, G ). For monolayer NS/PCs, cells were per-
meabilized with PBS-Tween/0.3% Triton X-100 following PFA 
fi xation. 
 Cell culture and neural induction of hPSCs 
 The iPS (Foreskin) 4 clone 1 and clone 2, abbreviated iPS1 
and iPS2 ( 42 ), and the hESC line ENVY (ES Cell International) 
were cultured as described ( 43, 44 ). Neuronal induction by nog-
gin (R and D, 500 ng/ml) was performed as described in ( 11 ). 
Noggin-treated cells were dissected after 14 days and were 
further subcultured in suspension in NBM together with bFGF 
(Millipore) and EGF (R and D, 20 ng/ml each) to form neuro-
spheres ( 45 ). 
 NS/PC monolayer culture 
 The monolayer culture of NS/PCs was generated as previ-
ously reported ( 46 ) with some modifi cations. Briefl y, two-week-old 
neurospheres cultured with NBM supplemented with bFGF 
and EGF were collected and dissociated by disaggregation with 
Trysin-EDTA (Invitrogen). The enzymatic reaction was stopped 
using soybean trypsin inhibitor (Sigma). The dissociated cells 
were seeded in NBM supplemented with growth factors onto 
precoated tissue culture dishes with laminin 1 µg/cm 2 (Sigma-
Aldrich) to generate a monolayer of NS/PCs. The medium was 
changed every second day. NS/PCs were further passaged with 
accutase (Sigma). Medium was changed every second day, and 
cells were cultured for three weeks. All experiments were consis-
tently conducted on less than passage 5 monolayered NS/PCs. 
 Neurosphere formation assay 
 Noggin-treated cells were harvested after 14 days by dissecting 
and further subcultured as neurospheres, in suspension in NBM 
together with bFGF and EGF (20 ng/ml each), in the presence 
or in the absence of LPA (complete with any inhibitor used), 
with medium changed every second day ( 39 ). Each condition was 
performed in at least eight individual wells and repeated in at 
least three independent experiments. Assessment of neurosphere 
formation was performed after 7 days. 
 Neuronal and glial differentiation of neurosphere 
 After two weeks in suspension, neurospheres cultivated in 
NBM with bFGF and EGF were plated as previously described 
( 11 ) onto poly-l-lysine/laminin-coated (Sigma, 10 and 5 µg/
ml, respectively) or poly-l-lysine/fi bronectin-coated (Millipore, 
10 µg/ml) dishes in NBM lacking growth factors to induce 
neuronal and glial differentiation, respectively, allowed to at-
tach, and incubated in the presence or in the absence of LPA 
(complete with any inhibitor used) for fi ve days ( 39 ). For each 
type of experiment, after attachment, medium was changed 
every second day. Pictures were taken of each individual well 
(inverted microscope Olympus IX71 and Cell IR software) fol-
lowing fi ve days in culture. The cells were then fi xed with 4% 
PFA/PBS. 
 Quantifi cation of neuron-forming spheres 
 Quantifi cation was performed by counting the number of 
spheres from which neuronal outgrowth was observable ( 39 ). 
In some cases neurospheres failed to attach, independently of 
the treatments, and these fl oating neurospheres were excluded 
from quantifi cation. 
understanding its impact, specifi cally on NS/PCs and 
progeny, is relevant to transplantation work. LPA might 
be the environmental cue that is able to modify the be-
havior of NS/PCs and their derivatives during infl amma-
tion after neurotrauma. 
 MATERIALS AND METHODS 
 Ethics 
 All experiments were approved by the Human Research Ethics 
Committees of the University of Melbourne (Approvals 0605017 
and 0830010). 
 Reagents 
 Dilutions of LPA (Sigma-Aldrich, Castle Hill, Australia) were 
made in 0.1% fatty acid-free BSA (fi nal concentration 0.01% 
BSA; Sigma-Aldrich). Cells were treated with LPA (up to 10 µM), 
LPA 1 /LPA 3 antagonists Ki16425 (Sigma-Aldrich, 10 µM), LY294002 
(Promega, 10 µM), Y27632 (Biomol, 1 µM), GW9662 (Cayman 
Chemicals, 1 µM), cell-permeable C3 Transferase (Cytoskeleton, 
1 ng/ml, pretreament 4 h),  Pertussis toxin (PTX, Biomol, 10 ng/
ml, pretreament 18 h). Unless otherwise specifi ed, inhibitors were 
added to cells 30 min prior to addition of LPA to the culture me-
dium on the fi rst incubation. 
 RT-PCR 
 mRNA was isolated from undifferentiated hPSCs, noggin-
treated hPSCs, NS/PCs in neurospheres, and monolayers of NS/
PCs using Dynabeads Oligo (dT)25 (Dynabeads). RT-PCR were 
conducted using High Capacity cDNA Reverse Transcriptase Kit 
(Applied Biosystems), following the manufacturer’s instructions. 
A negative control (  RT) consisting in the absence of reverse 
transcriptase was performed to check the absence of genomic 
DNA. qPCR was carried out using TaqMan Universal master mix 
(Applied Biosystems) and the 7900HT Fast Real-Time PCR system 
(Applied Biosystems) and TaqMan gene expression assays for 
 LPA 1–5 and  ATX (Applied Biosystems). TaqMan gene expression 
assays for  LPA 1 (Hs00173500_m1),  LPA 2 (Hs00173704_m1),  LPA 3 
(Hs00173857_m1),  LPA 4 (Hs00271072_s1),  LPA 5 (Hs01051307_
m1),  ATX (Hs00196470_m1),  PLA2-group IIA (Hs00179898_
m1),  ROCK1 (Hs01127699_m1), and  ROCK2 (Hs00178154_m1) 
were used (Applied Biosystems). The relative quantitation was 
achieved by applying the comparative CT method (   CT) in 
which the mRNA levels were normalized against the level of glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA (TaqMan 
gene expression assay Hs99999905_m1) or   -actin (Hs99999903_
m1) with  LPA 5 used as the reference. Q-PCR reaction of the non-
reverse-transcribed sample was also conducted for each Taqman 
probe above to check the genomic DNA contamination in the 
sample and the specifi city of the probes. 
 Immunofl uorescence 
 Following fi xation with paraformaldehyde (PFA) 4% for 10 
min, cells were blocked in a 10% fetal calf serum-PBS 0.1% 
Tween 20 (PBT, 60 min) and immunostained with the following 
primary antibodies: mouse anti-  III-tubulin (Millipore); rabbit 
anti-glutamate aspartate transporter (GLAST, Millipore); rabbit 
anti-glial fi brillary acidic protein (GFAP, DAKO); mouse anti-
A2B5 (Millipore); rabbit anti-nestin (Millipore); rabbit anti-
doublecortin (DCX, Abcam); mouse phospho-myosin light 
chain (MLC) 2 (Ser19); and rabbit phospho-cofilin (Ser3) 
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 LPA treatment in the maintenance of monolayer 
NS/PC culture 
 NS/PCs were seeded onto laminin-precoated 24-well plates in 
NBM supplemented with growth factor (bFGF and EGF, 20 ng/ml 
each). After two days, medium was changed and supplemented 
with LPA and fi xed in PFA 4% 18 h later. 
 Cell morphology assays of the differentiated neurons 
derived from monolayer NS/PC culture 
 Neurons cultured for three weeks on poly-l-lysine/laminin-
coated slides were placed on the heated stage of an inverted mi-
croscope (Olympus) equipped with phase-contrast optics and 
temperature control. During time-lapse recording, the plated 
neurons were maintained in 25 mM HEPES-buffered NBM (pH 
7.4) at 37°C and observed continuously using a camera con-
nected to time-lapse software (Axiovision and Olympus IX71). 
LPA at different concentrations (0.1, 1, and 10 µM) was applied 
during time-lapse recording. Images were acquired using 5 s in-
terframe intervals. 
 siRNA knockdown of ROCK 
 Monolayer NS/PCs were passaged into complete NBM media 
without antibiotic one day before transfection at 2.5–5 × 10 5 /
well in 6-well plates. Knockdown of ROCKI and/or ROCKII 
was performed using Dharmacon SMART pool ON-TARGET-
plus ROCK1 siRNA (L-003536-00-0005) and ON-TARGETplus 
ROCK2 siRNA (L-004610-00-0005), which were already demon-
strated to be specifi c in hESC ( 47 ). Control for transfection was 
done using ON-TARGETplus NonTargeting Pool (D-001810-
10-05). Specifi c siRNA (25 nM) for each pool was mixed with 
Dharmafect II, following Dharmacon siRNA Transfection’s pro-
tocol. Measurement of knockdown effi ciency and survival were 
respectively performed at 48 h and 72–96 h following transfec-
tion. Quantifi cation of  ROCKI and  ROCKII mRNA levels were 
determined by qPCR. Expression levels of corresponding genes 
were normalized to the housekeeping gene   -actin and ex-
pressed as the percentage level over the control. At 48 h post 
transfection, cells were passaged onto laminin-coated chamber 
slides. At 72 h post transfection, LPA (10   M) was added for 18 h 
prior to TUNEL assay. 
 Statistical analysis 
 All sets of experiments were performed at least three times in 
triplicate, unless specifi ed ( n refers to the number of indepen-
dent experiments performed on different cell cultures). Datasets 
were expressed as means ± SEM. Signifi cance of the differences 
was evaluated using the  t -test or the one- and two-way ANOVA 
followed by the Newman-Keuls test for multiple comparisons. 
Statistical signifi cance was established at * P < 0.05, ** P < 0.01, 
and *** P < 0.001. 
 RESULTS 
 Neural differentiated hPSCs express LPA 1–5 and LPA 
producing enzymes mRNA 
 We performed qPCR analysis of hPSCs at the different 
stages of progressive neural differentiation (undifferenti-
ated cells, noggin-treated cells, and neurospheres) to 
characterize their expression profi le ( Fig. 1 ).  All of the 
undifferentiated and the differentiated hPSCs expressed 
 LPA 1–5 ,  ATX , and  sPLA 2 mRNA ( Fig. 1 ), with LPA 2 and 
 Cell morphology assays 
 Six- to seven-day-old neurospheres cultured on poly-l-lysine/
laminin-coated slides were placed on the heated stage of an in-
verted microscope (Olympus) equipped with phase-contrast op-
tics and temperature control. During time-lapse recording, the 
plated neurospheres were maintained in 25 mM HEPES-buffered 
NBM (pH 7.4) at 37°C and observed continuously using a camera 
connected to Axiovision time-lapse software (Carl Zeiss). Various 
concentrations of LPA and/or selected inhibitors were applied 
during time-lapse recording. To observe reversibility of LPA’s ef-
fect, LPA was withdrawn from the culture medium and replaced 
by normal 25 mM HEPES-buffered complete medium, followed 
by time-lapse recording at indicated times. Images were acquired 
using 5 s interframe intervals. The pictures were then assessed for 
morphological modifi cations of plated neurosphere and neurite 
retraction. At least three independent experiments were per-
formed for each treatment. 
 Apoptosis and proliferation assays 
 Cell apoptosis was quantifi ed by measuring numbers of con-
densed nuclei with terminal transferase dUTP nick end labeling 
(TUNEL) immunocytochemistry. TUNEL analysis was performed 
using the In Situ Cell Death Detection Kit (Roche) following the 
manufacturer’s instruction. Proliferation was assessed by staining 
with Ki67 (Thermo Fisher Scientifi c, Clone SP6). Briefl y, day 7 
neurospheres were collected, manually dissociated, centrifuged 
onto glass slides (4 min at 1,000 rpm, Shandon Cytospin 4, 
Thermo Fisher Scientifi c), air dried, fi xed with 4% PFA, and per-
meabilized with 0.1% Triton X-100 before immunostaining with a 
TMR Red-conjugated TdT enzyme or Ki67, respectively. Apopto-
sis and proliferation were also assessed on laminin-plated, two-
week-old neurospheres treated with or without LPA (10   M, 18 h) 
as described in Ref.  39 . Cell nuclei were counterstained with 
DAPI. Specifi city of the staining was verifi ed by the absence of 
staining in negative controls without the TdT enzyme or negative 
isotype. Apoptosis and proliferation were respectively quantifi ed 
by manually counting TUNEL-positive cells and Ki67-positive cells 
as a percentage of total cell number, counting at least 1,000 cells 
per treatment by using Image J software (National Institutes of 
Health). 
 RhoA activation assay 
 Active RhoA was measured using the G-LISA RhoA activation 
assay biochem kit (Cytoskeleton, colorimetric assay) according to 
the manufacturer’s instructions. Briefl y, monolayered NS/PCs 
were cultured for two days in NBM supplemented with bFGF and 
EGF (20 ng/ml) until they reached 30–50% confl uency. Concen-
tration of bFGF and EGF was reduced to 10 ng/ml for one day 
and then removed overnight prior to treatment. Cells were 
treated or not with LPA 10 µM for 1, 3, 5, 15, and 30 min. Follow-
ing treatments, cells were rinsed twice with cold PBS, rapidly 
scraped, lysed in a cold premixed lysis buffer with protease in-
hibitor on ice, and centrifuged (1,000  g , 4°C, 1 min). Superna-
tants were collected and snap-frozen in liquid nitrogen. Some 
aliquots were taken for protein concentration measurement. Fol-
lowing adjustment of protein concentration, G-LISA was then 
processed according to manufacturer’s kit instruction. The opti-
cal density (OD) was read at 490 nm using a 96-well microplate 
reader (Bio-Rad). 
 NS/PC monolayer differentiation 
 To induce neuronal and astrocytic differentiation, the mono-
layer NS/PCs were replated onto poly-l-ornithine/laminin-
treated wells at 1–5 × 10 4 cells/cm 2 . Medium was changed every 
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(neurosphere stage). Similarly, an increase of  ATX mRNA 
expression was observed in both noggin-treated cells and 
neurospheres.  LPA 3 and  LPA 5 mRNA were downregulated 
upon neural differentiation, and no signifi cant modula-
tion was observed for  LPA 2 and  LPA 4 . Very low levels of 
 sPLA 2 were observed at all stages of differentiation. Similar 
trends were observed in the other lines tested ( Fig. 1E, F ). 
Given the similar trend of expression of  LPA 1–5 ,  ATX , and 
 sPLA 2 mRNA in neurospheres from the two clones of iPSCs, 
we assessed most biological effects of LPA in iPS1 and com-
pared them with hESCs. 
LPA 4 mRNA being the most abundant. LPA 5 mRNA was 
expressed at very low levels in neurospheres obtained from 
all lines relative to  LPA 1–4 ( Fig. 1A–C ). To examine the 
expression profi le of LPA receptors, ATX, and  sPLA 2 at 
each differentiation stage, the mRNA expression levels of 
each gene were presented in comparison to their corre-
sponding levels in undifferentiated hPSCs ( Fig. 1D–F ). 
 Fig. 1D provides an illustration of the data obtained with 
iPS1. Temporal upregulation of  LPA 1 mRNA expression 
was found during early differentiation (noggin-treated stage), 
followed by a downregulation during later differentiation 
 Fig.  1.  LPA 1–5 ,  ATX , and sPLA 2 gene expression profi le in neural differentiated hPSCs. (A–C) mRNA ex-
pression (2     Ct ) profi le of  LPA 1–5 ,  ATX in neurosphere relative to LPA 5, in iPS1 (A), iPS2 (B), and hESCs 
(C). (D–F) mRNA profi le of undifferentiated and progressively differentiated into NS/PCs (noggin-treated 
and neurosphere) relative to undifferentiated iPS1 (D), iPS2 (E), and hESCs (F). The mRNA expression 
levels were normalized against the level of  GAPDH mRNA (  Ct) with the level of  LPA 5 (A–C) or  LPA 1–5 ,  ATX , 
 and sPLA 2 of the undifferentiated hPSCs (D–F) used as the reference genes (   Ct). Data were obtained 
from at least three independent experiments and expressed as means ± SEM of triplicates of each sample. 
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neurosphere formation is dose dependent in iPS1 and 
hESCs and shows a similar trend in iPS2, although not sta-
tistically signifi cant ( Figs. 2C and  3A, F ). As exemplifi ed in 
 Fig. 2A–C in iPS1, LPA strongly inhibited sphere forma-
tion in a dose-dependent manner (LPA, 10 µM: 10.4 ± 
3.8% of sphere formation compared with control: 59.4 ± 
7.5%, n > 3,  P < 0.001;  Fig. 2A–C ). This effect was associ-
ated with a decrease in proliferation (36.11 ± 10.1% of 
 LPA inhibits neurosphere formation through activation 
of the Rho/ROCK pathway 
 We previously reported that one dose of LPA (10 µM) 
signifi cantly inhibits neurosphere formation of hESC-de-
rived NS/PCs, without further description of this effect 
( 39 ). Here, we observed a similar effect in two clones of 
iPSCs and characterized this in both iPSCs and hESCs 
( Figs. 2 and  3 ). Interestingly, LPA-mediated inhibition of 
 Fig.  2. LPA inhibits neurosphere formation of hPSC-derived NS/PCs. Representative images of neurosphere in the absence ( A ) or pres-
ence of LPA (10 µM, B) for seven days. (C) Quantifi cation of neurosphere formation in the absence (Control) or presence LPA at various 
concentrations. (D) Quantifi cation of proliferation (Ki67) and apoptosis (TUNEL) in neurospheres treated or not (Control) with LPA (10 µM) 
and/or Y27632 (1 µM) for seven days. (E–I) Quantifi cation of neurosphere formation in the absence (Control) or presence of LPA (10 µM) 
and/or Ki16425 (10 µM, E), GW9662 (1 µM, F), C3 (1 ng/ml, G), Y27632 (1 µM, H), and PTX (10 ng/ml, I). The specifi c inhibitors were 
preincubated as specifi ed in Materials and Methods prior to LPA addition and maintained in the culture medium for the entire differentia-
tion period. Data are expressed as mean ± SEM from at least three independent experiments. The statistical analysis was established by 
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same time, which cannot be controlled in three-dimen-
sional neurospheres. The adherent monolayered culture 
expressed the NS/PC marker nestin ( Fig. 4A , B ),  could be 
subcultured for several passages, reformed neurospheres 
in suspension culture ( Fig. 4C ), could be differentiated 
into neurons and glial cells ( Fig. 4D–F ) and also express 
mRNA for LPA receptors and producing enzymes ( Fig. 4I ). 
Similar trends in LPA-mediated effects were observed be-
tween suspension culture and adherent culture of NS/
PCs, thus allowing parallel conclusions to be made between 
the two culture systems ( Fig. 4J–M ). Adherent NS/PCs were 
cultured in the presence or absence of LPA, followed by Rho 
activation measurements by ELISA. A basal level of Rho acti-
vation was detected on control NS/PCs. As shown in  Fig. 4N , 
LPA induced a rapid increase of active RhoA (GTP-Rho) 
in NS/PCs, which was biphasic with an elevation that 
peaked at 1 min post exposure followed by a sustained but 
lower activity for at least 30 min. This result directly dem-
onstrates that LPA stimulates Rho in NS/PCs and that this 
activation critically modulates NS/PC expansion. 
 To exclude potential off-targets of the ROCK kinase in-
hibitor Y27632 despite its high specifi city, we further con-
fi rmed our results by a molecular approach consisting of 
knocking down  ROCKI and  ROCKII by siRNA in monolay-
ered NS/PCs, individually or together ( Fig. 4O, P ). Follow-
ing 48 h post transfection, single siRNA treatment for either 
 ROCKI or  ROCKII specifi cally knocked down its correspond-
ing gene while their dual knocking down resulted in 75.6 ± 
7.0% and 76.2 ± 4.3% downregulation of  ROCKI and  ROCKII 
mRNAs ( Fig. 4O ). When monolayered NS/PCs were knocked 
down for both ROCKI/ROCKII, the apoptosis induced by 
LPA was abolished, demonstrating the involvement of ROCK 
in LPA’s effect ( Fig. 4P ). 
 LPA inhibits the neuronal differentiation of iPSCs 
through the Rho/ROCK and PI3K/Akt pathways 
 LPA did not modify glial differentiation of iPSC-derived 
neurospheres but inhibited their neuronal differentiation 
( Fig. 5A –G ). This effect was dose dependent and ROCK 
and PI3K/Akt dependent ( Fig. 5H, I ). As shown in  Fig. 5I , 
LPA’s effect on human iPSC-derived NS/PCs was partially 
abolished by the sole application of Y27632 or LY294002 
but was abolished in the presence of both inhibitors. These 
effects were observed in both iPSC lines tested. As previ-
ously observed with hESC-derived neurospheres ( 39 ), we 
confi rm here that LPA acts through an inhibition 
of differentiation rather than by modifying proliferation or 
apoptosis of these two-week-old neurospheres. Indeed, 
neurospheres plated onto laminin in the presence of LPA 
(10 µM, 18 h) did not show modifi cation of Ki67 or TUNEL 
when compared with control conditions (no LPA;  Fig. 5J ). 
 LPA induces morphological rearrangements of hPSC-
derived early neurons through the Rho/ROCK pathway 
 After six days of plating, neurospheres had already given 
rise to   III-tubulin-positive early neurons, which radially 
migrate out from the edges of the neurospheres ( Fig. 6 ). 
 When incubated with LPA, these early neurons underwent 
rapid neurite retraction , leading to cell rounding (occurs 
Ki67-positive cells in LPA-treated cells versus 64.67 ± 5.84% 
in control conditions, n > 3,  P < 0.01;  Fig. 2D ) as well as an 
increase in apoptosis (LPA: 69.86 ± 9.1% of cells were 
TUNEL-positive versus 40.03 ± 5.9% in control, n > 3,  P < 
0.01;  Fig. 2D ). A similar trend was observed in hESCs, al-
though the decreased proliferation was not found to be 
statistically signifi cant ( Fig. 3J ). 
 Quantifying neurosphere formation frequency does 
not discriminate between apoptosis and proliferation but 
provides a reliable and robust measurement of NS/PC ex-
pansion and was used here to identify the signaling mecha-
nisms used by LPA during this process. The impact of LPA 
on neurosphere formation was found not to be mainly 
through its extracellular receptors LPA 1/3 , as pretreatment 
with Ki16425 at a dose that is specifi cally antagonistic to 
LPA 1/3 ( 48 ) did not modify LPA-mediated inhibition of 
sphere formation in the iPSCs but signifi cantly reduced the 
effect of LPA on hESC sphere formation ( Figs. 2E and  3B, 
G ). It is likely that the blockage of these receptors is compen-
sated by the other LPA receptors present in NS/PCs. Due to 
the lack of commercially available, specifi c LPA receptor an-
tagonists, the involvement of the other receptors was not as-
sessed in this study. Further, we decided not to use siRNA in 
these experiments because of the poor transfection effi -
ciency due to the three-dimensional structure of the sphere. 
Instead, siRNA knockdown of  ROCKI/II were performed on 
monolayered NS/PCs as explained below. In the presence of 
the selective PPAR  antagonist GW9662 ( 49 ), the effect of 
LPA was not modifi ed, suggesting that LPA does not act 
through PPAR  to inhibit neurosphere formation ( Fig. 2F ). 
 In all cell lines, the effect of LPA on sphere formation 
was abolished by pretreatment with either the specifi c Rho 
inhibitor C3 exoenzyme ( 50 ) ( Figs. 2G and  3C, H ) or with 
the p160 ROCK inhibitor Y27632 used at a dose specifi c to 
p160ROCK inhibition ( 51 ) ( Figs. 2H and  3D, F ), which 
alone have no marked effect, indicating that LPA acts 
through the Rho/ROCK pathway to inhibit neurosphere 
formation. Furthermore, when cells were incubated with 
PTX, which ADP-ribosylates   i proteins, LPA’s effect was 
maintained ( Figs. 2I and  3E, I ), suggesting that LPA’s ef-
fect is not G i/o mediated and is consistent with a G 12/13 
Rho-mediated mechanism. This data was confi rmed by 
measuring apoptosis and proliferation of NS/PCs in the 
presence of LPA and Y27632 ( Figs. 2D and  3J ). The sole 
application of Y27632 did not modify basal proliferation 
or apoptosis ( Figs. 2D and  3J ). As shown in  Fig. 2 in iPS1, 
LPA-induced apoptosis and LPA-reduced proliferation 
were abolished by Y27632 ( Fig. 2D ). Thus, this data indi-
cate that LPA acts through the Rho/ROCK pathway to in-
hibit neurosphere formation, at least by increasing cell 
apoptosis and by decreasing proliferation in iPS1. 
 LPA induces RhoA activation 
 To confi rm that LPA modulated NS/PC expansion by 
activation of the Rho/ROCK pathway, we measured Rho 
activity in NS/PCs by using an adherent culture of human 
NS/PCs derived from dissociated neurospheres. This pro-
tocol was favored over spheres, as the monolayer NS/PC 
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 Fig.  3. LPA inhibits neurosphere formation of iPS2- and hESC-derived NS/PCs. Quantifi cation of neurosphere formation in the absence 
(Control) or presence of LPA at various concentration in iPS2 (A–E) and hESCs (F–I), with or without Ki16425 (10 µM, B, G), C3 (1 ng/ml, 
C, H), Y27632 (1 µM, D, F), and PTX (10 ng/ml, E, I). (J) Quantifi cation of proliferation (Ki67) and apoptosis (TUNEL) in hESC neuro-
spheres treated or not (Control) with LPA (10 µM) and/or Y27632 (1 µM) for seven days. The specifi c inhibitors were preincubated as 
specifi ed in Materials and Methods prior to LPA addition and maintained in the culture medium for the entire differentiation period. Each 
panel represents a pool of at least three independent experiments, and data are expressed as means ± SEM. The statistical analysis was es-
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LPA, indicating that the mechanisms mediated by LPA are 
fundamental in neural differentiation and are not infl u-
enced by other variables often observed between different 
hESC/iPSC lines ( 53 ). 
 Our results show that both undifferentiated hPSCs and 
neural differentiated hPSCs express  LPA 1–5 mRNA, confi rm-
ing our previous RT-PCR data ( 8, 39, 54 ), and they show 
that  LPA 2 and  LPA 4 are the most abundant mRNA in undif-
ferentiated hPSCs and neurospheres. Modulation in the 
receptor expression profi le was observed following neural 
differentiation with an upregulation of  LPA 1 mRNA during 
the early neural commitment of hPSCs (noggin-treated 
stage), followed by its downregulation during later differen-
tiation (neurosphere stage). The mRNA expression profi le 
in hPSC-derived neurospheres shared some similar trends 
to the profi le observed in hESC-derived NEP ( 41 ) and in 
the monolayer NS/PCs, with  LPA 1,2,4 being the most ex-
pressed mRNA. The low level of  sPLA 2 expression and the 
presence of  ATX mRNA following neural differentiation, as 
exemplifi ed in this data, are consistent with the fact that 
 ATX expression is associated with neurogenesis ( 55 ). 
 As  LPA 1 shows its highest expression level at the nog-
gin stage, we assessed its involvement in neurosphere 
formation as readout of the impact of LPA on NS/PC 
expansion. Using the LPA 1–3 antagonist Ki16425, we ob-
served no signifi cant effect of this treatment on LPA’s ef-
fect in iPSCs and a partial inhibition in hESCs, suggestive 
that other receptors are involved in the inhibition of NS/
PC expansion by LPA. This is consistent with the fact that 
 LPA 2,4 are the most abundant mRNAs in NS/PCs from all 
cell lines. LPA receptors are coupled to multiple G pro-
teins, with LPA 1–5 coupled to G q, LPA 1,2,4,5 coupled to G 12 , 
LPA 1–4 coupled to G i , and LPA 4,5 also coupled to G s ( 1 ). 
PTX did not affect LPA’s effect on sphere formation, sug-
gesting that LPA acts independently of   i , either through 
G 12 and/or G q and/or the    subunits of G proteins. This 
is highly likely given that the main receptors present at 
either the noggin stage or neurosphere stage (LPA 2, 4 > 1 ) 
signal through G q and G 12 . Additionally, as LPA’s effect 
on NS/PC expansion is Rho/ROCK-mediated, it is also 
probable that the mechanism is G 12 dependant ( 56 ). Fur-
ther, we showed that LPA inhibits neuronal differentia-
tion of iPSC-derived NS/PCs through the PI3K/Akt and 
Rho/ROCK pathways, which are likely to be mediated 
by    and G 12 , respectively ( 56 ), and which is consistent 
with our previous data obtained with hESCs ( 39 ). Lastly, 
we describe that LPA induces morphological rearrange-
ments of early neurons in a Rho/ROCK manner, presum-
ably mediated by G 12 . Altogether, this data demonstrates 
the importance of LPA receptor-mediated signaling along 
the whole neural differentiation process. 
 We found that LPA promoted apoptosis of early human 
NS/PCs, as revealed by neurosphere formation assay, 
which is consistent with some NS/PC and neuroblast stud-
ies performed in rodents ( 16, 17, 38, 57, 58 ) but differs 
with others in which LPA improves cell survival ( 16, 38 ) or 
proliferation ( 13, 35, 59 ). In human cells, we previously 
showed that LPA does not modify apoptosis of older hESC-
derived NS/PCs ( 39 ) as, when two-week-old hESC-derived 
within minutes;  Fig. 6A–D and supplementary video I). 
These effects were dose dependent, starting at 1 µM, and 
reversible ( Table 1 and  Fig. 6E–G ).  The reversibility took 
longer when compared with the rapid retraction observed 
in the presence of LPA, but it suggest that the neurite re-
traction was not the result of cell death. 
 LPA-induced morphological rearrangements could be 
prevented by preincubation with C3 exoenzyme or Y27632 
( Table 1 ,  Fig. 6H–K , and supplementary video I), indicat-
ing that LPA acts through the Rho/ROCK pathway to in-
duce neurite retraction in early neurons derived from 
hPSCs. PTX and LY294002 had no effect on LPA-induced 
neurite retraction ( Table 1 ), indicating that this mecha-
nism is G  i and PI3K/Akt independent. Similar data were 
observed in early neurons derived from monolayered NS/
PC cultures ( Fig. 4K, L ). To further elucidate LPA’s role in 
neural development, we analyzed the impact of LPA on 
the actin-myosin cytoskeleton, assessing cofi lin and MLC, 
respectively, as these proteins are downstream effectors of 
ROCK ( 52 ). These experiments were performed on mono-
layered NS/PCs by immunohistochemistry to assess local-
ization of phospho-cofi lin and phospho-MLC. As shown in 
 Fig. 6L–O , although we did not observe an effect of LPA 
on phospho-cofi lin, LPA induced the phosphorylation of 
MLC, suggesting that it induces morphological rearrange-
ments through modifi cation of myosin. 
 DISCUSSION 
 LPA is bioactive lipid known to affect most cell types of 
the nervous system. Limited studies have addressed LPA’s 
role in the human CNS and in human neural cells. We 
previously described that LPA inhibits the neuronal dif-
ferentiation of hESC-derived NS/PCs and briefl y reported 
that LPA inhibits neurosphere formation of hESCs ( 39 ). 
Here we established a comprehensive in vitro system to 
assess the role of LPA at multiple stages of human neural 
differentiation using both hESCs and human iPSCs. We 
assessed whether these two different sources of human 
NS/PCs are equivalent in terms of LPA’s effects upon neu-
ralization by describing  LPA 1–5 ,  ATX , and s PLA 2 mRNA 
expression and by assessing whether effects previously 
observed with hESCs were retrieved in human iPSCs. We 
also characterized how LPA modifi es NS/PC expansion 
and the morphology of early human neurons. We observed 
a similar pattern of effects of LPA throughout the neural 
differentiation of hESCs and iPSCs. The three lines tested 
expressed LPA receptors and  ATX and  sPLA 2 mRNA with 
a similar profi le. In all NS/PCs tested, LPA increased cell 
death and inhibited neuronal differentiation without 
modifying glial differentiation. Furthermore, LPA induced 
morphological rearrangements in early neurons differen-
tiated from NS/PCs. In iPSC-derived NS/PCs, LPA also 
signifi cantly decreased proliferation, while a similar trend 
was observed in hESC-derived NS/PCs but without reach-
ing statistical signifi cance. Hence, our data shows generally 
consistent results across different iPSC and hESC lines, 
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tiation of human iPSCs, which is in agreement with our previ-
ous study using hESCs ( 39 ) and with data obtained in rodents 
( 58 ); although other studies found opposite effects in various 
NS/PCs and neuroblasts ( 14, 17, 18, 38, 59, 60 ). 
 Even though using similar protocols of maintenance of 
NS/PCs as monolayers, it is interesting to note that we ob-
serve some variations with data obtained on hESC-derived 
NEP ( 41 ). In particular, as shown in  Fig. 4 , we did not 
observe the growth effect of low doses of LPA on mono-
layers of NS/PCs described by others ( 41 ), but we showed 
neurospheres plated in conditions allowing differentiation 
were incubated with LPA for 18 h, no modifi cation in apop-
tosis or proliferation was detected by TUNEL or BrdU assays, 
respectively ( 39 ). Here we confi rmed this data using human 
iPSC-derived neurospheres. Further, others demonstrated 
that LPA increases growth of hESC-derived NEP ( 41 ), an ef-
fect observed at a concentration of up to 0.1 µM. In this study, 
that concentration already inhibited sphere formation but 
did not signifi cantly affect monolayered NS/PCs. Similarly, 
LPA inhibits neuronal differentiation but not glial differen-
 Fig.  4. Characteristics of adherent NS/PC in culture. (A–F) Representative images of plated NS/PCs showing brightfi eld (A) and im-
munostaining for nestin (red) and DAPI (blue, B). (C) Representative brightfi eld image of a neurosphere formed from plated NS/PCs. 
(D–F) Representative immunostaining of NS/PCs differentiated into neurons with   III-tubulin (green, D), DCX (red, E), and glial cells 
with GFAP (red, F) and DAPI counterstain (blue). (G) Rabbit and (H) mouse negative isotype controls. (I) mRNA expression (2     Ct ) 
profi le of  LPA 1–5 ,  ATX ,  and sPLA 2 in NS/PCs. For  LPA 1–5 and  ATX mRNA, expression levels were normalized against the level of GAPDH 
mRNA (  Ct) with the level of LPA 5 used as the reference gene (   Ct);  sPLA 2 was expressed compared with undifferentiated cells to show 
its very low level of expression. (J) Quantifi cation of proliferation (Ki67) and apoptosis (TUNEL) in plated NS/PCs treated or not (Con-
trol) with various doses of LPA (0.1–10 µM) for 18 h. (K, L) Representative images of early neurons from monolayered NS/PCs cells prior 
to treatment (K) and treated with LPA (10 µM) for 20 min (L) showing morphological rearrangements. (A–H, K, L) Data are representa-
tive pictures of at least three independent experiments. Scale bars are indicated within each image. (M) Quantifi cation of apoptosis 
(TUNEL) in plated NS/PCs treated or not (Control) with LPA (10 µM) and/or Y27632 (1 µM) for 18 h. (N) Time course of activated RhoA 
(GTP Rho) by LPA measured at 490 nm by ELISA in monolayered NS/PCs. (O) mRNA expression profi le of  ROCKI and  ROCKII following 
knockdown of  ROCKI and/or  ROCKII by siRNA for 48 h. mRNA expression levels were normalized against the level of   -actin mRNA and 
are expressed as percentage of control. (P) Quantifi cation of apoptosis (TUNEL) in siRNA control pool (Control, LPA) or ROCK I- and 
ROCK II-treated monolayer NS/PCs subsequently incubated in the absence or presence of LPA (10 µM) for 18 h. (I, J, M–P) Data were 
obtained from at least three independent experiments and are expressed as means ± SEM of triplicates of each sample. The statistical analy-
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 Fig.  5. LPA inhibits neuronal differentiation of human iPSCs without modifying apoptosis and proliferation. (A–C) Immunostaining of 
glial differentiation of neurospheres plated onto fi bronectin and incubated in the presence of LPA (fi ve days, 10 µM) with GLAST (A), 
GFAP (B), or A2B5 (C) antibodies with DAPI counterstain (blue). (D, E)   III-tubulin immunostaining (red) and DAPI counterstain (blue) 
of neurospheres plated onto laminin and incubated in the presence of LPA (fi ve days, 10 µM, D) or in its absence (E). (F) Mouse and (G) 
rabbit negative isotype controls. Data are representative pictures of at least three independent experiments. Scale bars: A–C, F–G: 20 µm; 
D, E: 100 µm. (H, I) The percentage of neuron-forming neurospheres was quantifi ed in the presence of various concentrations of LPA (H) 
or in the absence (Control) or presence of LPA (10 µM) and/or Y27632 (1 µM) and/or LY 294002 (10 µM) (I). (J–L) Proliferation and 
apoptosis by Ki67 and TUNEL quantifi cation, respectively, of two-week-old neurospheres plated onto laminin in the absence (Control) or 
in the presence of LPA (10 µM) for 18 h in iPS1 (J), iPS2 (K), and hESCs (L). (H–L) Data are expressed as means ± SEM of at least three 
independent experiments. The statistical analysis was established by one-way ANOVA analysis (H, I) or  t -test (J–L); * P < 0.05; ** P < 0.01; 
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the discrepancies in LPA-mediated effects between the stud-
ies, which could refl ect a variation in the developmental 
state (either more or less restricted) of the human NS/PC 
populations in use. 
 LPA has been extensively studied for its prominent effect 
in inducing cytoskeletal rearrangements. In particular, LPA 
is shown to induce neurite retraction and cell rounding 
through the Rho/ROCK pathway in rodent immortalized 
neuroblasts and PC12 ( 26, 61 ). We observed a similar pattern 
of morphological changes in early human neurons, which, 
following exposure to LPA, underwent immediate and rapid 
retraction, cell rounding, and migration to form cell clusters 
and compaction in a Rho/ROCK-dependent manner. Inter-
estingly, in hESC NEP, LPA induced ROCK-dependent mor-
phological rearrangements, but these were observed to be 
slow, peaking around 5 h ( 41 ). 
that LPA induces apoptosis of the monolayer NS/PCs at a 
dose that was not previously tested in hESC NEP. Our data, 
using two different sources of human NS/PCs and two dif-
ferent protocols for maintenance (neurospheres and mono-
layers), indicates that the observed pro-apoptotic effects of 
LPA are consistent, regardless of the NS/PC origin. It is 
thus likely that the variations between our data and those of 
Hurst and colleagues in terms of cell growth at low concen-
trations of LPA are due to a difference in the populations of 
human cells studied. In particular, the main difference be-
tween the protocols for generating a monolayer of NS/PCs 
is in the derivation of the NS/PCs themselves. We use dis-
sociated neurospheres to obtain a monolayered culture, 
whereas the NEP used by Hurst and colleagues were directly 
obtained from hESCs without going through a neurosphere 
stage ( 41, 46 ). This variation in protocol might account for 
 Fig.  6. LPA induces morphological rearrangements in early neurons derived from hPSCs. Representative images of cells prior to treat-
ment (0, A, E) and treated with LPA (10 µM) for 1, 5, and 10 min (1 ′ , 5 ′ , 10 ′ , C–D); or treated with LPA (10 µM) for 10 min (F) and then 
incubated with normal medium for 18 hrs (G); or preincubated with C3 (1 ng/ml, H) or Y27632 (1 µM, J), prior to addition of LPA 
(10 µM, I, K) for 10 min. Data presented were obtained with iPS1. Square shows example of an area showing retractions. Scale bar: 100 µm. 
(L–O) Representative immunostained images of early neurons in control or following LPA treatment (10 µM, 15 min) with phospho-cofi lin 



















Supplemental Material can be found at:
1204 Journal of Lipid Research Volume 54, 2013
( 74 ). Following CNS injury, ischemia, or events that dam-
age the blood brain barrier, LPA-like activity increased 
within the cerebrospinal fl uid , levels of LPA within the 
CNS increased up to 10 µM ( 75–78 ), and levels of ATX 
increased within astrocytes neighboring a lesion of the 
adult rat brain ( 79 ). Our data using human cells suggest 
that the presence of LPA in regions of neurogenesis within 
the CNS may modify NS/PC survival and differentiation. 
Our data also suggest that high levels of LPA have the abil-
ity to be pro-apoptotic on human NS/PCs, to bias their 
differentiation toward glial cells and to induce neurite re-
traction and cell rounding of early neurons and thus limit 
the regenerative responses to injury. This is relevant to en-
dogenous neurogenesis and might explain low levels of 
neurogenesis observed following trauma, with LPA being 
a limiting factor of genesis. This fi nding is also relevant to 
transplantation of human stem or progenitor cells within 
the CNS, as the infl ammation present or generated by the 
transplantation procedure itself may induce increased lev-
els of LPA which could limit neurogenesis and repair. Our 
data also suggest that neurogenesis may be enhanced by 
blockers of LPA signaling, such as LPA antibodies that we 
recently demonstrated were able to abolish LPA’s effect 
on human NS/PCs in vitro and improve neuronal survival 
and functional recovery following spinal cord injury in 
vivo ( 80 ). Such a mechanism has already been proved with 
sphingosine-1-phosphate, as blocking its signaling en-
hances endogenous NS/PC migration to the injury site 
following trauma ( 81 ). 
 CONCLUSION 
 LPA plays a broad role in human NS/PCs and their neu-
ral derivatives, regulating expansion, differentiation, and 
morphology. We showed that in hPSC-derived NS/PCs, 
LPA increases apoptosis, decreases proliferation, inhibits 
neuronal differentiation, and induces rapid morphological 
rearrangements in early neurons. All these effects are at 
least Rho/ROCK dependent. We observed that the effects 
of LPA on NS/PCs are insensitive to PTX treatment, indicat-
ing no involvement of   i but suggestive of the involvement 
of   12 ,   q , or   /  in these biological effects. LPA-induced 
activation of Rho/ROCK is likely to be G 12 mediated, as this 
is the common upstream G protein for Rho and has been 
reported to be involved in the pro-apoptotic effect of LPA 
through LPA 1,2,4 ( 16 ). Thus, our data demonstrate the con-
sistency in the effect of LPA across various sources of hu-
man NS/PCs, rendering hESCs and human iPSCs valuable 
in vitro models for studying lysophospholipid signaling in 
human neural cells. Our data also highlight the importance 
of the Rho/ROCK pathway in human NS/PC expansion 
and differentiation. It is thus possible that blocking LPA sig-
naling in vivo, in which levels increase following trauma, 
would enhance neurogenesis.  
 The authors thank Guizhi Sun and Daniella Herszfeld (Monash 
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 The importance of the Rho/ROCK pathway in stem 
cell survival is now established. The ROCK inhibitor 
Y27632 signifi cantly increases hESC single-cell survival 
( 62, 63 ) and NS/PCs following neurosphere dissociation 
( 64 ). Further, upon dissociation to single cells, the Rho/
ROCK pathway is activated and responsible for modu-
lating cell-cell contact-induced apoptosis in hESCs ( 65 ), 
NS/PCs ( 64 ), and neurons ( 66 ), an effect associated with 
MLC phosphorylation in hESCs ( 47 ). Moreover, in neu-
rons, Rho/ROCK activation induces apoptotic membrane 
blebbing by stimulating MLC phosphorylation ( 66 ) and 
has associations to neuronal death following spinal cord 
injury ( 67 ). Other data suggest that ROCK inhibition 
may not act directly by reducing apoptosis but rather by 
desensitizing cells to their environment and thus limit-
ing apoptosis ( 68 ). 
 Our data showing LPA’s activation of RhoA is in line 
with data obtained by others in other stem and progenitor 
cells ( 1 ) and are the fi rst demonstration of human-derived 
NS/PCs at various stages of differentiation. A large body of 
evidence shows that LPA acts through the Rho pathway to 
modify cell survival, apoptosis, and proliferation in diverse 
types of cells by mediating cell shape/focal adhesion al-
teration ( 38, 69, 70 ). Our current data demonstrate that 
LPA activates RhoA in human NS/PCs and implicate this 
pathway in LPA-induced apoptosis, decreased prolifera-
tion, and together with the PI3K/Akt pathway, LPA inhibi-
tion of neuronal differentiation of human NS/PCs. 
Furthermore, activation of this pathway is essential to LPA-
induced morphological rearrangements in human NS/
PC-derived early neurons. 
 Adult NS/PCs are present in the CNS, predominantly in 
neurogenic regions, such as the subventricular zone and 
hippocampus. They have been reported to migrate to sites 
of injury and tumors ( 71 ), effects likely to be linked to the 
repair of damaged tissue. Furthermore, evidence suggests 
that NS/PCs contribute to neurogenesis in the adult 
mouse and human following stroke ( 72, 73 ). Similar data 
were observed following brain injury in the juvenile rat 
 TABLE 1. Neurite retraction in early neurons derived from hPSCs 
Tested Agents Neurite Retraction (+/  )
Control   
LPA 0.1 µM   
LPA 1 µM +
LPA 10 µM +
Y27632 1 µM   
Y27632 + LPA 10 µM   
C3   
C3 +LPA 10 µM   
PTX   
PTX + LPA 10 µM +
LY294002   
LY294002 + LPA 10 µM +
LPA’s effect in neurite retraction among tested agents in human 
NS/PCs. Early neurons differentiated from hPSCs were incubated or not 
with LPA and/or Y27632 (1 µM, 30 min preincubation), C3 transferase 
(1 ng/ml, 4 h preincubation), PTX (10 ng/ml, 18 h preincubation), and 
LY 294002 (10 µM, 30 min preincubation). +, retraction;   , no retraction. 
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